NTRK1 and neoplasm: Interestingly, the EGFR tyrosine kinase receptor, overexpressed in many different tumors and well known for its oncogenic functions in tumor cells, has been recently proposed as a key regulator also of immune cells, as it has been found able to inhibit CTLs through different mechanisms [27].